Cargando…

The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy

PURPOSE: Variation in sensitivity to glucocorticoids observed in healthy population is influenced by genetic polymorphisms of the glucocorticoid receptor gene (NR3C1). N363S, ER22/23EK, and Bcl I have been previously described as glucocorticoid-sensitivity modulating polymorphisms. We investigated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabó, Viktória, Borgulya, Gábor, Filkorn, Tamás, Majnik, Judit, Bányász, Ilona, Nagy, Zoltán Zsolt
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765477/
https://www.ncbi.nlm.nih.gov/pubmed/17563720
_version_ 1782173155469557760
author Szabó, Viktória
Borgulya, Gábor
Filkorn, Tamás
Majnik, Judit
Bányász, Ilona
Nagy, Zoltán Zsolt
author_facet Szabó, Viktória
Borgulya, Gábor
Filkorn, Tamás
Majnik, Judit
Bányász, Ilona
Nagy, Zoltán Zsolt
author_sort Szabó, Viktória
collection PubMed
description PURPOSE: Variation in sensitivity to glucocorticoids observed in healthy population is influenced by genetic polymorphisms of the glucocorticoid receptor gene (NR3C1). N363S, ER22/23EK, and Bcl I have been previously described as glucocorticoid-sensitivity modulating polymorphisms. We investigated whether these variants may contribute to steroid-induced ocular hypertension and if they play a role as protective or risk factors during exogenous glucocorticoid administration. METHODS: We examined 102 patients who underwent photorefractive keratectomy and received topical steroids (either fluorometholone 0.1% or prednisolone acetate 0.5% alone or combined) as part of postoperative therapy. The choice of steroid depended on course of wound healing and regression. Variations in intraocular pressure (IOP) levels in response to steroid therapy were observed. To genotype DNA, allele-specific PCR amplification was applied for the N363S polymorphism, and PCR-based restriction fragment length polymorphism analysis was performed to examine the Bcl I and the ER22/23EK polymorphisms. We separately analyzed data from three groups of patients: those who received fluorometholone only; those who were initially given fluorometholone then later switched to prednisolone acetate; and those who received prednisolone acetate only. Covariance analysis with forward stepwise variable selection was carried out. RESULTS: In cases where prednisolone acetate was administered, we found a significant correlation between N363S heterozygosity and steroid-induced ocular hypertension. ER22/23EK and Bcl I polymorphisms do not have a major influence on the risk of developing steroid-induced ocular hypertension. CONCLUSIONS: Genotyping of high risk steroid responders may allow an individual therapy to avoid steroid-induced ocular hypertension. The N363S polymorphism may have a clinical significance in the future.
format Text
id pubmed-2765477
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-27654772009-11-11 The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy Szabó, Viktória Borgulya, Gábor Filkorn, Tamás Majnik, Judit Bányász, Ilona Nagy, Zoltán Zsolt Mol Vis Research Article PURPOSE: Variation in sensitivity to glucocorticoids observed in healthy population is influenced by genetic polymorphisms of the glucocorticoid receptor gene (NR3C1). N363S, ER22/23EK, and Bcl I have been previously described as glucocorticoid-sensitivity modulating polymorphisms. We investigated whether these variants may contribute to steroid-induced ocular hypertension and if they play a role as protective or risk factors during exogenous glucocorticoid administration. METHODS: We examined 102 patients who underwent photorefractive keratectomy and received topical steroids (either fluorometholone 0.1% or prednisolone acetate 0.5% alone or combined) as part of postoperative therapy. The choice of steroid depended on course of wound healing and regression. Variations in intraocular pressure (IOP) levels in response to steroid therapy were observed. To genotype DNA, allele-specific PCR amplification was applied for the N363S polymorphism, and PCR-based restriction fragment length polymorphism analysis was performed to examine the Bcl I and the ER22/23EK polymorphisms. We separately analyzed data from three groups of patients: those who received fluorometholone only; those who were initially given fluorometholone then later switched to prednisolone acetate; and those who received prednisolone acetate only. Covariance analysis with forward stepwise variable selection was carried out. RESULTS: In cases where prednisolone acetate was administered, we found a significant correlation between N363S heterozygosity and steroid-induced ocular hypertension. ER22/23EK and Bcl I polymorphisms do not have a major influence on the risk of developing steroid-induced ocular hypertension. CONCLUSIONS: Genotyping of high risk steroid responders may allow an individual therapy to avoid steroid-induced ocular hypertension. The N363S polymorphism may have a clinical significance in the future. Molecular Vision 2007-04-27 /pmc/articles/PMC2765477/ /pubmed/17563720 Text en http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Szabó, Viktória
Borgulya, Gábor
Filkorn, Tamás
Majnik, Judit
Bányász, Ilona
Nagy, Zoltán Zsolt
The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy
title The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy
title_full The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy
title_fullStr The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy
title_full_unstemmed The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy
title_short The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy
title_sort variant n363s of glucocorticoid receptor in steroid-induced ocular hypertension in hungarian patients treated with photorefractive keratectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765477/
https://www.ncbi.nlm.nih.gov/pubmed/17563720
work_keys_str_mv AT szaboviktoria thevariantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT borgulyagabor thevariantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT filkorntamas thevariantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT majnikjudit thevariantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT banyaszilona thevariantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT nagyzoltanzsolt thevariantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT szaboviktoria variantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT borgulyagabor variantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT filkorntamas variantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT majnikjudit variantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT banyaszilona variantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy
AT nagyzoltanzsolt variantn363sofglucocorticoidreceptorinsteroidinducedocularhypertensioninhungarianpatientstreatedwithphotorefractivekeratectomy